Answers are grounded in this paper and cite their sources.
Skeletal muscle is increasingly recognized as an active endocrine organ capable of exerting protective effects on distal tissue homeostasis through the secretion of bioactive factors, including myokines. While inter-tissue communication of skeletal muscle has been described for various tissues, its role in lung biology has remained largely unexplored, though evidence for this interaction is now emerging. Chronic obstructive pulmonary disease, a chronic condition characterized by both pulmonary dysfunction and systemic manifestations such as skeletal muscle wasting, provides a strong rationale to explore the role of the muscle secretome in lung health and pathology. In this review, we explore the concept of skeletal muscle-lung crosstalk with a focus on myokines as key mediators. Through literature search, we selected a subset of myokines for which published studies have specifically investigated their effects on lung disease. We highlight four myokines-irisin, apelin, MG53, and Metrnl-that have demonstrated protective effects on lung tissue across a range of experimental models. These factors exert anti-inflammatory, antioxidative, antifibrotic, and cytoprotective effects by modulating key signaling pathways. Through these mechanisms, myokines contribute to the preservation of lung tissue integrity, regulation of inflammation in the lungs, maintenance of lung mitochondrial function, and support of lung tissue repair processes. Collectively, these findings support a paradigm in which skeletal muscle actively contributes to lung health. Elucidating this crosstalk may reveal novel strategies to enhance pulmonary resilience and repair, particularly through interventions that deploy the muscle secretome.
No takes yet. Share an insight, caveat, or question.
Manse et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: